Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192550 · ClinicalTrials.gov registry record · NA
Functional Usability and Feasibility Testing of the Profound Matrix™ System
A NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by Candela Corporation.
- Completed
- Registry status
- NA
- Development phase
- 193
- Enrollment target
- 5
- Study locations
NCT06192550 is a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic that has completed, run by Candela Corporation. The registered enrollment target is 193 participants, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (72% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT06192550, a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 193 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a non-randomized, multi-center, open-label clinical trial evaluating the efficacy and clinical feasibility of the Profound Matrix device for electrocoagulation and for treatment of wrinkles and acne scars. Subjects will receive up to three (3) treatments with the Matrix Pro applicator or up to five (5) treatments with the Sublime and/or Sublative Radiofrequency (RF) applicators.
Conditions Studied
Interventions
- DEVICE Profound Matrix™ System
Study Locations (5)
New York
- NY Derm - New York
- OptiSkin - New York
Massachusetts
- Candela Institue for Excellence - Marlborough
North Carolina
- Laser & Vein Specialists of the Carolinas - Charlotte
Other
- Syneron Medical - Yokneam Illit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06192550
The ClinicalTrials.gov registry entry for NCT06192550 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (72% higher). The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Profound Matrix™ System is the first listed.
NCT06192550 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06192550 about?
NCT06192550 is a clinical study titled "Functional Usability and Feasibility Testing of the Profound Matrix™ System". This is a non-randomized, multi-center, open-label clinical trial evaluating the efficacy and clinical feasibility of the Profound Matrix device for electrocoagulation and for treatment of wrinkles and acne scars. Subjects will receive up to three (3) treatments with the Matrix Pro applicator or up ...
What is the current status of trial NCT06192550?
This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2020-10-28. Estimated completion is 2023-12-29.
What conditions does trial NCT06192550 study?
This clinical trial studies the following conditions: Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic.
What interventions are being tested in trial NCT06192550?
The interventions under investigation include: Profound Matrix™ System (DEVICE).
Who is sponsoring clinical trial NCT06192550?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06192550 being conducted?
This trial has 5 study locations across Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Wrinkle
All registered trials for this condition
Acne Scars - Mixed Atrophic and Hypertrophic
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.